These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27452413)

  • 1. Novel approaches to preclinical research and TB vaccine development.
    Walker KB; Guo M; Guo Y; Poecheim J; Velmurugan K; Schrager LK
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S12-5. PubMed ID: 27452413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TB vaccines in clinical development.
    Ginsberg AM; Ruhwald M; Mearns H; McShane H
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S16-20. PubMed ID: 27470538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TB biomarkers, TB correlates and human challenge models: New tools for improving assessment of new TB vaccines.
    Kaufmann SH; Fortune S; Pepponi I; Ruhwald M; Schrager LK; Ottenhoff TH
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S8-S11. PubMed ID: 27402312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advocacy, partnership and political commitment for TB vaccine research.
    Olesen OF; Chan S; Chappell J; Guo Y; Leite LC
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S26-9. PubMed ID: 27402313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic studies and novel clinical research approaches that impact TB vaccine development.
    Evans TG; Churchyard GJ; Penn-Nicholson A; Chen C; Gao X; Tait DR; Hatherill M
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S21-5. PubMed ID: 27461190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of tuberculosis and novel mechanisms of vaccine activity.
    Schrager LK; Izzo A; Velmurugan K
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S3-7. PubMed ID: 27450395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for new TB vaccines: Stop TB Working Group on TB Vaccine Development.
    Fruth U; Young D
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):151-5. PubMed ID: 14974759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant live vaccine candidates against tuberculosis.
    Kaufmann SH; Gengenbacher M
    Curr Opin Biotechnol; 2012 Dec; 23(6):900-7. PubMed ID: 22483201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real world TB vaccines: clinical trials in TB-endemic regions.
    Doherty TM
    Vaccine; 2005 Mar; 23(17-18):2109-14. PubMed ID: 15755580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.
    Marinova D; Gonzalo-Asensio J; Aguilo N; Martin C
    Expert Rev Vaccines; 2017 Jun; 16(6):565-576. PubMed ID: 28447476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z; Charters TJ
    Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi India.
    Atmakuri K; Penn-Nicholson A; Tanner R; Dockrell HM
    Tuberculosis (Edinb); 2018 Dec; 113():55-64. PubMed ID: 30514514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successes and failures in human tuberculosis vaccine development.
    Zenteno-Cuevas R
    Expert Opin Biol Ther; 2017 Dec; 17(12):1481-1491. PubMed ID: 28927311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tuberculosis vaccine development.
    Sacksteder KA; Nacy CA
    Expert Opin Biol Ther; 2002 Oct; 2(7):741-9. PubMed ID: 12387673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of clinical models for the evaluation of human TB vaccines.
    O'Shea MK; McShane H
    Hum Vaccin Immunother; 2016 May; 12(5):1177-87. PubMed ID: 26810964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis vaccine development: research, regulatory and clinical strategies.
    Brennan MJ; Morris SL; Sizemore CF
    Expert Opin Biol Ther; 2004 Sep; 4(9):1493-504. PubMed ID: 15335316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?
    Smaill F; Xing Z
    Expert Rev Vaccines; 2014 Aug; 13(8):927-30. PubMed ID: 24935214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.